Intuitive Ventures

This week, Vivian Emmely Golfin, MD attended MedTech Strategist's #InnovationSanDiego where she spoke on the panel "Raising Capital from Strategics." Joined by leaders from Edwards Lifesciences, Olympus Innovation Ventures, Johnson & Johnson MedTech, and Medtronic the keynote discussion focused on the medtech investment landscape.

Today, Jotthe Kannappan spoke on a panel at MedTech World's #MedTechMalta2024, discussing venture investment across the medtech landscape. If you’re attending tomorrow’s sessions, don’t miss the MedTech Startup Pitch Competition, where Jotthe will be one of the judges.

Today, Deloitte published Life Sciences and Healthcare Predictions 2030, featuring ten predictions on how the world could look in the next five years. The report highlights major trends in healthcare and life sciences, identifies key challenges to be addressed, and examines current evidence to forecast what the future may hold. Intuitive Ventures' $150 million Fund II - which was announced in late 2023 - was cited in the "Life sciences M&A, divestments and restructuring" section. Be sure to check out the full report here: https://lnkd.in/ewtX5jT4

Murielle Thinard McLane joined Amber Therapeutics, Lightstone Ventures, and Oxford Science Enterprises at LSI Europe this week, discussing Amber Therapeutics' $100M Series A and the future of neuromodulation for mixed urinary incontinence. Learn more about Amber Therapeutics and why Intuitive Ventures invested in the company here: https://lnkd.in/eXbSFimW

Highlights from Day 2-morning panels! We hit the ground running with four engaging panels this morning, featuring: Prosperity in Adversity: Doubling Down on Smart Investments in Uncertain Times ? Ido Hadari (Moderator) — Hadari Consulting ? Rafael Beyar — ALIVE Israel HealthTech Fund ? Assaf Barnea — Sanara Ventures ? Sharon Handelman-Gotlib —Shela Health ? Daniel Allen, PhD — Unorthodox Ventures Amber Therapeutics: $100M Series A, and the Future of Neuromodulation for Mixed Urinary Incontinence ? Henry Peck (Moderator) — LSI ? Aidan Crawley — Amber Therapeutics ? Caroline Gaynor — Lightstone Ventures ? Murielle Thinard McLane — Intuitive Ventures ? Liliane Chamas, PhD — Oxford Science Enterprises Medtech’s Conundrum: Where Will Capital and Liquidity Come From? ? Bill Little — Orchestra BioMed ? Michael Wasserman — Elevage Medical Technologies ? Alexander Schmitz — Endeavour Vision ? David Kereiakes — Windham Capital Partners ? Diana Saraceni — Panakes Partners Raising Capital from Family Offices ? Alexei Mlodinow — SIA ? Tyler Wanke — Wanke Family Office ? John Slump — Atraverse Medical ? Pablo Prieto — CG Health Ventures ? Marie-Louise Little — TW Medical A/S (Family Office) We’re about halfway through LSI Europe ‘24 - Still much more on the way. #LSIEurope24

If you're attending LSI Europe this week, don't miss Murielle Thinard McLane's panel discussing Amber Therapeutics tomorrow at 9:55am.

If you're attending LSX USA Congress today, don't miss Jotthe Kannappan's panel "Put it on your Pitchdeck: Meeting Investor Expectations" at 4:40pm!

Health Tech Challengers 2024 applications close next week! Join the pitch battle in Barcelona on December 4-5 and showcase your innovation alongside the brightest health tech stars in front of the leading investors and industry pros. #HTC2024 https://lnkd.in/exTySNqD

Congratulations XII Medical on the Series B raise. Learn more about Intuitive Ventures' investment here:

LSI Europe kicks off in September. Murielle Thinard McLane will join the stage with Amber Therapeutics discussing its recent $100 million Series A, one of the largest Series A rounds in Europe for a MedTech company. Ahead of the conversation, learn more about Amber Therapeutics and why Intuitive Ventures invested in the transformative company here: https://lnkd.in/gmQak4kh